| Temperance Taylor, FNP-C | |
|
400 Warren Ave Ste 2l-a, East Providence, RI 02914-3826 | |
| (401) 305-0080 | |
| (888) 655-0696 |
| Full Name | Temperance Taylor |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 400 Warren Ave Ste 2l-a, East Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861056608 | NPI | - | NPPES |
| 1164040069 | Medicaid | RI |
| Entity Name | Taylor Health Enterprises, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164040069 PECOS PAC ID: 0244645620 Enrollment ID: O20231107002236 |
News Archive
AMICAS, Inc., a leader in image and information management solutions, will launch AMICAS RIS(TM) Version 5.5 at RBMA's 2009 Fall Educational Conference in Chandler, AZ, from October 11 to 13. AMICAS will be in booth #203.
A new voter survey sponsored by the ACT-AD Coalition (Accelerate Cure/Treatments for Alzheimer's Disease) finds that three-quarters of Americans nationwide and across party lines say it is personally important to them to find a cure or to prevent Alzheimer's disease, while a similar proportion of the national electorate say they look to Congress to make it "a national priority" to speed up the Food and Drug Administration's (FDA) review process in specific ways for therapies that slow, halt or reverse the disease.
Write out every letter in the human genome, one A, C, T or G per millimeter, and the text would be 1,800 miles long, roughly the distance from New York to Colorado.
A Penn Medicine-developed drug has received orphan status in Europe this week for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.
Utah residents may have thought they were done fighting about Medicaid expansion last November. But when Utah lawmakers opened a new legislative session in late January, they began pushing through a bill to roll back the scope and impact of an expansion that voters approved in a ballot measure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Temperance Taylor, FNP-C 400 Warren Ave Ste 2l-a, East Providence, RI 02914-3826 Ph: (401) 305-0080 | Temperance Taylor, FNP-C 400 Warren Ave Ste 2l-a, East Providence, RI 02914-3826 Ph: (401) 305-0080 |
News Archive
AMICAS, Inc., a leader in image and information management solutions, will launch AMICAS RIS(TM) Version 5.5 at RBMA's 2009 Fall Educational Conference in Chandler, AZ, from October 11 to 13. AMICAS will be in booth #203.
A new voter survey sponsored by the ACT-AD Coalition (Accelerate Cure/Treatments for Alzheimer's Disease) finds that three-quarters of Americans nationwide and across party lines say it is personally important to them to find a cure or to prevent Alzheimer's disease, while a similar proportion of the national electorate say they look to Congress to make it "a national priority" to speed up the Food and Drug Administration's (FDA) review process in specific ways for therapies that slow, halt or reverse the disease.
Write out every letter in the human genome, one A, C, T or G per millimeter, and the text would be 1,800 miles long, roughly the distance from New York to Colorado.
A Penn Medicine-developed drug has received orphan status in Europe this week for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.
Utah residents may have thought they were done fighting about Medicaid expansion last November. But when Utah lawmakers opened a new legislative session in late January, they began pushing through a bill to roll back the scope and impact of an expansion that voters approved in a ballot measure.
› Verified 2 days ago